Bridging India’s Healthcare Gap with Global-Standard Endometriosis Treatment
Endometriosis, a painful and often misdiagnosed condition, affects 10-15% of Indian women, yet many go years without proper diagnosis or treatment. Women struggling with severe pelvic pain, menstrual disorders, and unexplained infertility often face fragmented care, outdated treatments, and limited access to minimally invasive surgeries. Despite affecting 247 million women globally, endometriosis remains one of the least understood conditions in India’s healthcare system.
For the first time in India, a dedicated multidisciplinary center is changing this reality. Kokilaben Dhirubhai Ambani Hospital (KDAH) has become the first and only hospital in India to receive the EuroEndoCert certification from the European Endometriosis League. This prestigious accreditation, previously awarded only to leading hospitals in Europe and the U.S., validates KDAH’s world-class treatment model, setting a new benchmark for women’s healthcare in India.
This recognition is not just an award: it is a transformational shift in how endometriosis is treated in India. The certification ensures that KDAH follows the same advanced diagnostic and treatment protocols as those used in Germany, France, and the United Kingdom. Patients now have access to gold-standard treatments, including robotic-assisted laparoscopic surgery, specialized pain management, and fertility-preserving interventions.
Why India Needed a Global-Standard Endometriosis Center
Unlike in Germany and Australia, where endometriosis is widely recognized and treated early, India has no standardized treatment guidelines, leading to delayed diagnosis and poor patient outcomes. Studies suggest that Indian women often wait over a decade before being correctly diagnosed, compared to the global average of 7-10 years.
A report by the World Health Organization (WHO) confirms that 50% of women with endometriosis experience infertility, yet India lacks a coordinated approach to managing both conditions together. Unlike hospitals in the U.S. and the U.K., which integrate gynecology, pain management, and reproductive medicine, most Indian hospitals focus only on surgery, leaving patients without long-term disease management solutions.
KDAH’s certified Endometriosis Clinic changes this model entirely by offering a comprehensive, patient-first approach. It brings together gynecologists, radiologists, pain specialists, colorectal surgeons, and fertility experts: ensuring that women receive holistic, research-backed treatment rather than temporary symptom relief.
A Step Forward for Indian Women’s Health & Infertility Treatment
The impact of endometriosis on fertility remains one of its most devastating consequences. Research shows that 40-50% of women diagnosed with the condition struggle to conceive, as scar tissue, inflammation, and hormonal imbalances affect the ovaries and fallopian tubes. Many women only discover they have endometriosis when they face difficulties getting pregnant.
Kokilaben Hospital is tackling this issue head-on by integrating advanced fertility treatments into its endometriosis care model. This includes:
- Specialized laparoscopic and robotic-assisted surgeries designed to remove lesions without damaging ovarian reserves.
- Personalized hormonal therapy protocols that help preserve egg quality while managing symptoms.
- Dedicated fertility counseling and ART (Assisted Reproductive Technologies), including In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI) for endometriosis patients.
By adopting these evidence-based protocols, KDAH ensures that women suffering from endometriosis receive both effective pain management and fertility support, helping them build families without unnecessary delays.
How KDAH’s EuroEndoCert Recognition Transforms Women’s Healthcare in India
Before this certification, endometriosis treatment in India was inconsistent, with most hospitals relying on outdated techniques. The introduction of EuroEndoCert standards now places KDAH on par with the world’s top endometriosis treatment centers in France and Sweden.
The certification confirms that KDAH is following:
- European-standard diagnostic guidelines, reducing misdiagnosis rates.
- Minimally invasive robotic and laparoscopic surgeries, leading to faster recovery and reduced recurrence rates.
- Pain management strategies that go beyond surgery, incorporating nerve-block therapies and neuromodulation techniques.
- Comprehensive patient education and awareness initiatives, ensuring that women seek treatment earlier rather than waiting years for a diagnosis.
A Landmark Moment for Women’s Healthcare Policy in India
Beyond transforming patient care, this certification has broader policy implications for India’s healthcare system. Currently, India spends less than $5 million annually on endometriosis research, compared to $120 million in the U.S. and $78 million in Australia.
KDAH’s leadership in this field could drive national-level changes, including:
- Implementation of endometriosis screening programs in hospitals across India.
- Inclusion of endometriosis in national health policies, similar to the UK’s Endometriosis Action Plan.
- More government funding for research, leading to better treatment accessibility for all Indian women.